SEPTIN9 and ovarian carcinoma: Methylation of SHOX2 or SEPT9 was detected in ascites samples of patients suffering from different malignancy entities including, among others, ovarian cancer, hepatic or pancreatic cancer, gallbladder or bile duct cancer, and non-Hodgkin lymphoma (Table 4, Additional file 1).